If the Crossfire debate at the American Urological Association (AUA) virtual annual meeting is any indication, advocates for transperineal (TP) biopsies face an uphill battle in persuading U.S.
About two million American men undergo transrectal biopsies each year to diagnose prostate cancer or to monitor low-risk and favorable intermediate-risk prostate cancers for active surveillance (AS).
MADRID — For patients who undergo prostate biopsy, patient-reported adverse effects and attitudes are similar when either a transperineal approach or the more traditional transrectal approach is used, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback